Online Exclusives

Online Exclusives

FDA Issues Guidelines for Regulating Health Artificial Intelligence

The FDA provided new guidance on the regulation of mobile health software and clinical decision support (CDS) tools that use artificial intelligence (AI). The...

Democrats and Republicans Unveil Competing Drug Pricing Bills

Lowering drug costs is a major bipartisan voter issue, but tensions between parties have been escalating as Democrats introduced a bill that would allow...

FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma

The U.S. Food and Drug Administration (FDA) approved the quadruplet regimen consisting of daratumumab, bortezomib, thalidomide, and dexamethasone to treat adult patients with newly...

NSTC Developing New Plans to Reduce Foreign Influence on U.S. Research

Co-chair of the National Science and Technology Council (NSTC) Kelvin Droegemeier, PhD, is developing new requirements for what information researchers must disclose to receive...
Research espionage

Foreign Scientists With Ties to China May Be Stealing U.S. Research

The National Institutes of Health (NIH) and the FBI have launched an investigation into foreign scientists who are allegedly stealing biomedical research from institutions...

Will the FDA’s Suggestions Help Curb Drug Shortages?

Drug shortages, especially of older and less expensive medications, are increasing, causing hospitals to ration lifesaving treatments. According to a report released in late...

Number of Plaintiffs in Roundup Cases Skyrockets

Chemical and pharmaceutical manufacturer Bayer is facing tens of thousands of lawsuits claiming its Roundup herbicides cause cancer. The number of plaintiffs filing lawsuits against...

Doctors Cancel Treatments as Immune Globulin Shortage Continues

As a severe shortage of immune globulin (IG) continues, doctors, hospitals, and treatment centers nationwide are forced to cancel, ration, and cut doses. The...

Are Results From Direct-to-Consumer Genetic Tests Reliable?

Results from genetic testing kits that consumers can purchase online or in stores may be unreliable and should not serve as the basis for...

Many New Drugs Benefit from Taxpayer-Funded Research

An analysis published in BMJ found that, over the last decade, one in four new medicines benefitted from publicly funded late-stage research or spinoff...
Advertisement

Current Issue

December 2019, Volume 5, Issue 15

This issue examines the hidden costs of participating in clinical trials, explores the pediatric hematology/oncology workforce, and more.